Establishment Labs Holdings Inc. (ESTA)
Nasdaq · Healthcare · Medical Devices
$66.47+3.76%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $2.0B
- Forward P/E
- 1107.8
- 52-week range
- $38.38 – $97.59
- 52-week change
- +62.88%
- EPS (trailing)
- −$1.30
- Analyst rating
- 1.2 Strong buy
- Next earnings
- Nov 4, 2026
Fiscal year to Dec 2025
- Revenue
- $211M (+27.13%)
- Net income
- −$51.1M
- Operating margin
- −18.5%
- Diluted EPS
- −$1.72
- Free cash flow
- −$56.9M
From the company’s annual report on SEC EDGAR.
About Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
Headquarters: Austin, United States · 1,004 employees · establishmentlabs.com